Delayed hypersensitivity to influenza virus in man.
Delayed hypersensitivity to influenza antigen has been demonstrated in man by means of skin tests and 'in vitro' lymphocyte transformation. Adjuvanted influenza vaccine enhances this response, in contrast to non-adjuvanted vaccine in commercial use.
D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral; D004305:Dose-Response Relationship, Drug; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage; D007273:Injections, Intramuscular; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology; D008934:Mitogens / Q000494:pharmacology; D009975:Orthomyxoviridae / Q000276:immunology*; D012867:Skin / Q000276:immunology; D012882:Skin Tests
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007252:Influenza Vaccines; D037102:Lectins; D008934:Mitogens